Record Information |
---|
Version | 2.0 |
---|
Creation Date | 2010-04-14 00:15:01 UTC |
---|
Update Date | 2014-12-24 20:26:19 UTC |
---|
Accession Number | T3D3667 |
---|
Identification |
---|
Common Name | Cytochalasin B |
---|
Class | Small Molecule |
---|
Description | Cytochalasins are mycotoxins that have the ability to bind to actin filaments and block polymerization and the elongation of actin. As a result, they can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. Cytochalasins also have the ability to permeate cell membranes, prevent cellular translocation, cause cells to enucleate, and affect other aspects of biological processes unrelated to actin polymerization. Cytochalasin B is an alkaloid isolated from the fungus Helminthosporium dermatioideum, as well as hormiscium species and rhoma species. (5, 2, 3, 10) |
---|
Compound Type | - Amide
- Amine
- Ester
- Ether
- Fungal Toxin
- Mycotoxin
- Natural Compound
- Organic Compound
|
---|
Chemical Structure | |
---|
Synonyms | Synonym | (3E,5S,9R,11E,12aS,13S,15S,15aS,16S,18aS)-16-Benzyl-5,13-dihydroxy-9,15-dimethyl-14-methylene-6,7,8,9,10,12a,13,14,15,15a,16,17-dodecahydro-2H-oxacyclotetradecino[2,3-d]isoindole-2,18(5H)-dione | (7S,13E,16R,20R,21E)-7,20-Dihydroxy-16-methyl-10-phenyl-24-oxo[14]cytochalasa-6(12),13,21-triene-1,23-dione | (E,E)-16-Benzyl-6,7,8,9,10,12a,13,14,15,15a,16,17-dodecahydro-5,13-dihydroxy-9,15-dimethyl-14-methylene-2H-oxacyclotetradec[2,3-d]isoindole-2,18(5H)-dione |
|
---|
Chemical Formula | C29H37NO5 |
---|
Average Molecular Mass | 479.608 g/mol |
---|
Monoisotopic Mass | 479.267 g/mol |
---|
CAS Registry Number | 14930-96-2 |
---|
IUPAC Name | 16-benzyl-5,13-dihydroxy-9,15-dimethyl-14-methylidene-2H,5H,6H,7H,8H,9H,10H,13H,14H,15H,15aH,16H,17H,18H,18bH-oxacyclotetradeca[3,2-e]isoindole-2,18-dione |
---|
Traditional Name | cytochalasen-B |
---|
SMILES | CC1C2C(CC3=CC=CC=C3)NC(=O)C22OC(=O)\C=C\C(O)CCCC(C)C\C=C\C2C(O)C1=C |
---|
InChI Identifier | InChI=1S/C29H37NO5/c1-18-9-7-13-22(31)15-16-25(32)35-29-23(14-8-10-18)27(33)20(3)19(2)26(29)24(30-28(29)34)17-21-11-5-4-6-12-21/h4-6,8,11-12,14-16,18-19,22-24,26-27,31,33H,3,7,9-10,13,17H2,1-2H3,(H,30,34)/b14-8+,16-15+ |
---|
InChI Key | InChIKey=GBOGMAARMMDZGR-LFKALUBKSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as cytochalasins. These are cytochalasans in which the hydrogenated isoindolone bears a benzyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Cytochalasans |
---|
Sub Class | Cytochalasins |
---|
Direct Parent | Cytochalasins |
---|
Alternative Parents | |
---|
Substituents | - Lactone cytochalasin skeleton
- Cytochalasin
- Isoindolone
- Isoindoline
- Isoindole
- Isoindole or derivatives
- Monocyclic benzene moiety
- Pyrrolidone
- Benzenoid
- 2-pyrrolidone
- Cyclic alcohol
- Pyrrolidine
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxamide group
- Carboxylic acid ester
- Lactam
- Lactone
- Organoheterocyclic compound
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Monocarboxylic acid or derivatives
- Organopnictogen compound
- Organic oxygen compound
- Alcohol
- Organonitrogen compound
- Carbonyl group
- Organic oxide
- Hydrocarbon derivative
- Organic nitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Exogenous |
---|
Cellular Locations | |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | |
---|
Biological Roles | |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Appearance | Felted needles from acetone. (14) |
---|
Experimental Properties | Property | Value |
---|
Melting Point | 221-223°C | Boiling Point | Not Available | Solubility | 1.280 mg/L | LogP | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | Deposition Date | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03dl-0000900000-878f3c18257df92c699c | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-01ox-2003900000-113bec8ef7184f11ab16 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-114l-6903000000-865180a2511963431147 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0000900000-afbc43afc29bcbd93c1d | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-01u0-0019700000-2545d40311da57562553 | 2016-08-03 | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0006-6109300000-bd57090aa6bef521c99f | 2016-08-03 | View Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Oral, dermal, inhalation, and parenteral (contaminated drugs). (4) |
---|
Mechanism of Toxicity | Cytochalasins are known to bind to the barbed, fast growing plus ends of microfilaments, which then blocks both the assembly and disassembly of individual actin monomers from the bound end. Once bound, cytochalasin essentially caps the end of the new actin filament. One cytochalasin will bind to one actin filament. By blocking the polymerization and elongation of actin, cytochalasins can change cellular morphology, inhibit cellular processes such as cell division, and cause cells to undergo apoptosis. Cytochalasin B also inhibits glucose transport and platelet aggregation. It blocks adenosine-induced apoptotic body formation without affecting activation of endogenous ADP-ribosylation in leukemia HL-60 cells. (2, 3, 10, 11) |
---|
Metabolism | Not Available |
---|
Toxicity Values | LD50: 11 mg/kg (Intraperitoneal, Rat) (12) |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | No indication of carcinogenicity to humans (not listed by IARC). |
---|
Uses/Sources | Cytochalasin B is isolated from a fungus, Helminthosporium dermatioideum, as well as hormiscium species and rhoma species. (5) |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Major biological effects of cytochalasins include inhibition of the division of cytoplasm, reversible inhibition of cell movement, induction of nuclear extrusion, inhibition of such processes as phagocytosis, platelet aggregation and clot retraction, glucose transport, thyroid secretion, and release of growth
hormone. Some cytochalasins have been shown to have developmental effects. Cytochalasin B also causes gradual but marked decline in intracellular levels of putrescine and spermidine. (1, 13) |
---|
Symptoms | Not Available |
---|
Treatment | Consider activated charcoal after gastrointestinal absportion. Nitroprusside is recommended to reverse peripheral ischemia secondary to vasoconstriction and for the treatment of hypertension. Anticoagulant therapy with intravenous heparin is also recommended. (6) |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
PubChem Compound ID | 5368686 |
---|
ChEMBL ID | CHEMBL56897 |
---|
ChemSpider ID | 4519910 |
---|
KEGG ID | Not Available |
---|
UniProt ID | Not Available |
---|
OMIM ID | |
---|
ChEBI ID | Not Available |
---|
BioCyc ID | Not Available |
---|
CTD ID | Not Available |
---|
Stitch ID | Not Available |
---|
PDB ID | Not Available |
---|
ACToR ID | Not Available |
---|
Wikipedia Link | Cytochalasin_B |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | T3D3667.pdf |
---|
General References | - Sunkara PS, Nishioka K, Rao PN: Cytochalasin B inhibits polyamine biosynthesis in HeLa cells. Eur J Cell Biol. 1981 Dec;26(1):154-7. [7327176 ]
- Haidle AM, Myers AG: An enantioselective, modular, and general route to the cytochalasins: synthesis of L-696,474 and cytochalasin B. Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12048-53. Epub 2004 Jun 18. [15208404 ]
- Cooper JA: Effects of cytochalasin and phalloidin on actin. J Cell Biol. 1987 Oct;105(4):1473-8. [3312229 ]
- Peraica M, Domijan AM: Contamination of food with mycotoxins and human health. Arh Hig Rada Toksikol. 2001 Mar;52(1):23-35. [11370295 ]
- Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group. JAMA. 1979 Dec 7;242(23):2562-71. [490882 ]
- Grond S, Sablotzki A: Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923. [15509185 ]
- Rumack BH POISINDEX(R) Information System Micromedex, Inc., Englewood, CO, 2010; CCIS Volume 143, edition expires Feb, 2010. Hall AH & Rumack BH (Eds): TOMES(R) Information System Micromedex, Inc., Englewood, CO, 2010; CCIS Volume 143, edition expires Feb, 2010.
- The Merck Index. 9th ed. Rahway, New Jersey: Merck & Co., Inc., 1976., p. 366
- Cole, R. J. and R. H. Cox. Handbook of Toxic Fungal Metabolites. New York: Academic Press, Inc., 1981., p. 281
- Cytochalasin. Wikipedia. Last Updated 12 April 2010. [Link]
- Cytochalasin B. Wikipedia. Last Updated 16 June 2009. [Link]
- Fermentek Biotechnology 2009. MSDS for Cytochalasin B. [Link]
- Sigma Aldrich 1996. Technical Bulletin AL-126: The Cytochalasins. [Link]
- Drugs.com [Link]
|
---|
Gene Regulation |
---|
Up-Regulated Genes | Not Available |
---|
Down-Regulated Genes | Not Available |
---|